State of Wyoming’s NextCure NXTC Stock Holding History

State of Wyoming’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-218	Closed	-$3.37K	–	1748
2023 Q3	$3.37K	Buy	+218	New	+$4.16K	﹤0.01%	1556

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

State of Wyoming's NXTC Position: Q4 2023 in Review

State of Wyoming sold out of NextCure (NXTC) in Q4 2023, closing a stake of 218 shares — an estimated $3.37K sold.

State of Wyoming first reported a position in NXTC in Q3 2023 and held it in 1 quarter. The position peaked at $3.37K in Q3 2023. 43 funds tracked by Wall St. Rank hold NXTC as of Q4 2023.

State of Wyoming reported no remaining NextCure position as of Q4 2023 after selling out during the quarter.
State of Wyoming sold 218 NextCure shares in Q4 2023, an estimated $3.37K.
State of Wyoming first reported a position in NextCure in Q3 2023 and held it in 1 quarter.
State of Wyoming's NextCure position peaked at $3.37K in Q3 2023.
43 funds tracked by Wall St. Rank held NextCure as of Q4 2023.

Based on State of Wyoming's 13F filing for Q4 2023, filed 15 Feb 2024.